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BOSMAN, G. J. C. G. M., J. G. E. JANZING, I. G. P. BARTHOLOMEW, A. J. M. DE MAN, F. G. ZITMAN AND W. J. DE GRIP. 
Erythrocyte aging characteristics in elderly individuals with beginning dementia. MEUROBIOL AGING 18(3) 291-295, 1997.— An 
increase in erythrocyte-bound IgG and enhanced breakdown of the erythrocyte anion exchanger band 3, characteristics of normal 
erythrocyte aging, are observed in old, healthy individuals when compared with young donors. These findings indicate that the rate of 
cellular aging increases with organismal aging. Results from previous studies on the same parameters have suggested that the 
erythrocyte aging process is disturbed in patients in advanced stages of Alzheimer type dementia, and in individuals with Down’s 
syndrome who show no signs of dementia. In this study we find no changes in erythrocyte aging parameters in old individuals in 
beginning stages of dementia of various etiologies. We conclude that, in general, characteristics of disturbed erythrocyte aging cannot 
serve as presymptomatic markers of Alzheimer-type dementia. © 1997 Elsevier Science Ir,c.
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SENILE dementia of the Alzheimer type (SDAT) is a syndrome 
with a heterologous etiology (20,22), However, the final neuro- 
pathological lesions, plaques, and tangles, are identical for all 
patients. Because plaques, tangles, and cell loss (or shrinkage) are 
also observed— be it to a much smaller extent—in healthy indi­
viduals of advanced age, the pathophysiology of SDAT has been 
characterized as an accelerated and/or disturbed neuronal aging 
process (20).
However, too little is known about the normal neuronal aging 
process to falsify this hypothesis. In contrast, the final stages of the 
erythrocyte life are well defined (14). Structural changes in band 3, 
the erythrocyte anion transporter [AE1 of the anion exchanger 
gene family; (4)], do not only lead to characteristic functional 
changes, but also to neoantigen activity and binding of autologous 
IgG. Cell-bound IgG, either or not in combination with comple­
ment activation (16), leads to recognition and removal of old 
erythrocytes by the immune system (14).
Earlier, we measured some parameters of this paradigm (IgG 
content, anion transport characteristics, AE1 breakdown) in eryth­
rocytes from patients in advanced stages of senile dementia of the 
Alzheimer type (SDAT), multiinfarct dementia (MID), and from 
age-matched control donors (3). Our results led us to the conclu­
sion that the erythrocyte aging process is disturbed in patients with 
SDAT. We reached an identical conclusion with regard to the 
erythrocyte aging process in donors with Down’s syndrome (4). 
Recent findings support the hypothesis that Alzheimer-specific
changes can be found at the level of the erythrocyte membrane 
(23), The changes in erythrocytes from individuals with Down’s 
syndrome who showed no signs of dementia (4) indicated that 
aberrant erythrocyte aging characteristics might already be detect­
able before the neuropsychological symptoms of dementia. Such a 
finding might be important for early diagnosis. Therefore, we 
measured erythrocyte aging characteristics (anion exchange, AE1 
breakdown, IgG content) in elderly individuals with beginning 
dementia, and compared them with age-matched, old controls and 
with much younger control donors. Here we present the results of 
these investigations.
METHOD
Subjects
The subjects were 27 patients with senile dementia of the 
Alzheimer type (SDAT), 17 patients with multiinfarct dementia 
(MID), 9 patients with mixed dementia (SDAT/MID), and 2 
control groups of subjects without dementia: one age-matched 
(AMC; N  =  14) and one young control group (YC; N  = 8). The 
YC were coworkers of the authors (28 ± 5 years). All other 
subjects were residents of local homes for the elderly, who took 
part in a longitudinal study on psychiatric symptoms in dementia. 
The present study comprises patients in the more beginning stages 
of dementia than the patients from a psychogeriatric institution 
examined previously (3). Informed consent was obtained from all
1 Requests for reprints should be addressed to Dr. G. Bosman, Institute of Cellular Signalling, Department of Biochemistry-FMW 160, Faculty of Medical 
Sciences, University of Nijmegen, P.O. Box 9101, NL-6500 HB Nijmegen, The Netherlands.
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TABLE 1
DEMOGRAPHIC CHARACTERISTICS
SDAT MID SDAT/MID AMC
Age* 85,3 ±  5,3 85.8 ±  5.8 87.2 ±  4 4 84.8 ±  6.3
Education* 6.5 ±  1.1 6.9 ±  1.5 7.3 ±  2 2 8.2 ±  3.2Î
Sex (%) 
Male 15 0 11 14
Female 85 100 89 86
MMSE§ 18.7 ±  3.9 18.0 ±  3.6 20.0 ±  2.9 22.1 ±  2 M
* In years.
t  AMC >  SDAT, p <  0.05.
+ AMC >  SDAT and AMC >  MID, p <  0.05 (one-way ANQVA; Tukey-B 
procedure). All values are given as the mean ±  SD.
§ Mini-Mental State Examination. For more details see the Method section,
participants in the study. The demographic characteristics are 
presented in Table 1.
Clinical Measurements
All subjects were scored on two cognitive screening instru­
ments, the Mini-Mental State Examination (7) and the Short 
Blessed Test (12). Furthermore, they had undergone standardised 
examinations using the Clinical Assessment Battery as developed 
by the Consortium to Establish a Registry for Alzheimer’s Disease
(17), including medical history, current medication, heteroanam­
nesis, neuropsychological investigation, physical and neurological 
examinations, a scheme for laboratory investigations, and a psy­
chiatric diagnosis using the Geriatric Mental State Examination
(6). Using this information, the demented subjects received a 
diagnosis of dementia compatible with the DSM-III-R criteria (i). 
According to their Hachinski score (10), they were divided into 
three subgroups: SDAT (score 0-4), SDAT/MID (score 5 and 6), 
and MID (score ^7). The age-matched control group consisted of 
subjects who did not fulfill the DSM-III-R criteria of dementia. 
The following exclusion criteria for demented and control subjects 
were used (17): communication problems interfering with test 
completion (severe hearing problems, severe aphasia), cognitive 
impairment caused by alcohol abuse, Parkinson’s disease requiring 
medication, major depression, specific neurological disease with 
dementia (with the exception of cerebrovascular disorders and 
Alzheimer’s disease), or an incomplete Hachinski score.
Blood Collection
Five to ten milliliters of blood, collected with EDTA as an 
anticoagulant, served for all assays. The assays were performed on 
the major erythrocyte fraction, representing “middle-aged” cells
(2). Separation of plasma, platelets, leukocytes, and young, mid­
dle-aged and old red blood cells was performed on the day of 
collection by differential centrifugation and density separation (3).
Eiythrocyle-Bound IgG
The amount of membrane-bound immunoglobulin G (IgG) was 
measured on intact erythrocytes using an enzyme-linked antiglob­
ulin test (3).
Anion Transport
Erythrocyte anion transport characteristics were determined by 
measuring initial rate of efflux of 35S-labeled sulfate (10 mCi/ 
mmol; Amersham, Buckinghamshire, UK) under exchange condi­
tions as a function of the sulfate concentration (2,3,13). Km, the 
sulfate concentration at which the rate equals half the maximal 
velocity Vmax, was determined from the initial, linear part of the 
velocity vs. concentration graph (2,3).
Immunochemical Analysis
Erythrocyte membranes were prepared by hypotonic lysis in 
the presence of EDTA, EGTA, and diisopropylfiuorophosphate as 
protease inhibitors (3). Band 3 polypeptides were analyzed by 
sodium dodecylsulfate-polyacrylamide gelelectrophoresis and im- 
munoblotting using standard techniques described before (3). The 
reactivity of the antisera against human erythrocyte band 3 
(MK1B3 against the whole protein and PMB3 against the mem­
brane domain) have been described before (3,4). Quantitative 
analysis of the extent of band 3 fragmentation was performed with 
a densitometer (GS-670) and analysis program (Molecular Ana­
lyst) from Bio-Rad Laboratories (Hercules, CA).
The clinical and neuropsychological data of the patients were 
only revealed and combined with the data from the biochemical 
studies after the latter had been completed.
RESULTS
Erythrocyte-Bounci Immunoglobulin G
The amount of erythrocyte-bound IgG did not differ signifi­
cantly between the demented and healthy, age-matched donor 
groups (Fig. 1), and was in the same range as reported before for 
healthy, old-aged people [3.6 ±  0.9 fgm/1000 cells; (3,4)], This 
value is higher than that found for a relatively young (28 ±  5 
years) control group (1.8 ±  0.8 fgm/1000 cells), confirming earlier 
results (4). In contrast with earlier findings in patients in an 
advanced stage of dementia of the Alzheimer type (3)> we did not 
find a significant increase in erythrocyte-bound IgG for the SDAT 
group. Exclusion of the extremely high IgG values (Fig, 1) does 
not significantly affect these conclusions.
Anion Transport Characteristics
The mean values of Vmox and Km of sulfate exchange did not 
differ significantly between the various donor groups, and were not 
different from the previously reported values for erythrocytes of 
young or aged control groups [Table 2; (3,4)]. It is noteworthy, 
however, that 9 of the 11 donors with Vmax values that were 
significantly lower than the mean (control) value (12.1 ±  2.9 
(xmol/1010 cells/min), belong to the patient groups (6 SDAT; 2 
SDAT/MID; 1 MID). The numbers of individuals with a Km
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fragmentation had a significantly higher IgG content (2.5 ± 0.5 
fgm/1000 cells; n = 19) vs. when compared with erythrocytes 
showing less fragmentation (1.6 ± 0.6 fgm/1000 cells; n = 17).
Blood Chemistry
Measurement of erythrocyte, thrombocyte, and leukocyte num­
bers, and related parameters (hemoglobin, mean cellular volume, 
etc.) did not indicate any disturbances in cellular homeostasis in 
the patient groups as compared with the control groups. The serum 
concentrations of sodium, potassium, chloride, bicarbonate, and 
calcium, as well as those of glucose, creatinine, and urea, were 
within the normal range. There was a highly significant (/- = 0.52, 
p  <  0.001, n — 47) positive correlation between Vmax of sulfate 
exchange and hemoglobin content. We found no significant 
difference between the patient and control groups in the extent and 
type of medicines used. There was no significant correlation 
between any of the erythrocyte aging parameters and use of 
medicine, with one notable exception. The value of the Vmax of 
sulfate exchange was significantly correlated with the use of 
acetylsalicylic acid (r = 0.46, p <  0.001, n = 57).
DISCUSSION
The erythrocyte aging process seems to be accelerated in aged 
individuals. The increased percentage of reticulocytes, the in­
creased percentage of erythrocytes containing IgG, and the in­
crease in erythrocyte IgG content in old rats are all considered to 
be signs of increased removal and compensatory erythrocyte 
formation in aged individuals (15). Our present findings, which 
show an increase in erythrocyte IgG content in healthy old people 
and an increase in breakdown of erythrocyte band 3, confirm this 
conclusion for aging humans. The increased fragmentation of band 
3 in the elderly supports the hypothesis that breakdown of band 3 
accompanies the generation of senescent erythrocyte-specific an­
tigens, and, thus, in the binding of IgG (2,14). The Km and VmaK 
values of sulfate exchange, however, did not differ significantly 
between old and young donors. As sulfate transport is 10,000 times 
slower than that of the physiological-chloride/bicarbonate ex­
change (18), these parameters may not be sensitive enough to 
detect small changes. Together, these data indicate that in old 
individuals the rate of the erythrocyte aging process is increased. 
An increased susceptibility to (calcium-activated) proteases, pos­
sibly due to a decrease in antioxidant activity, has been suggested 
for the erythrocyte aging process (13), as well as for cellular aging 
in general (11,19). A more detailed description of the structural 
differences in band 3 and its fragmentation products in old vs. 
young erythrocytes, and in erythrocytes from young vs. those of 
old donors, will be instrumental in understanding the underly­
ing processes.
Despite the large increase in knowledge about the composition 
of plaques and tangles in Alzheimer’s disease-affected brain areas, 
the processes that underly neuronal degeneration and death are far 
from understood (20,22). The neuropathological and the neuropsy­
chological characteristics of AD indicate a disturbance and/or 
acceleration of the normal neuronal aging process (5). In addition, 
numerous data indicate that AD/SDAT may have specific systemic 
manifestations (24). From these observations, we postulated that 
acceleration or disturbance of the cellular aging process in patients 
with AD/SDAT might be detectable at the level of the erythrocyte 
membrane. Our first results did indeed show an increase in 
erythrocyte IgG content, a change in band 3 fragmentation 
patterns, and a decrease in the Km of sulfate exchange in AD/ 
SDAT, but not in multiinfarct dementia patients, when compared 
with a group of age-matched control donors (3). These findings 
were supported by reports of protein-related differences at the 
surface of erythrocytes between control and SDAT patients (23), 
and of irregularly shaped erythrocytes in some SDAT patients (9). 
Thus, die membrane characteristics of patients in advanced stages 
of AD/SDAT led us to the conclusion that the erythrocyte aging 
process might be disturbed in these patients (3). Measurements of 
the same parameters in individuals with Down’s syndrome of 
various ages and in various stages of dementia resulted in the 
hypothesis that changes in the erythrocyte aging process might be 
detectable before the onset of dementia (4). However, in the 
present study we found no disease-specific differences in any of 
the erythrocyte aging characteristics in aged patients with begin­
ning dementia, compared with age-matched controls. This differ­
ence between the findings in two donor groups, who were in the 
same age range but in different stages of dementia, could be due to 
various causes: 1) Although the methods used by us to establish 
the diagnosis of dementia and SDAT are as accurate as presently 
possible (see the section Clinical Measurements in the Method 
section), it can not be excluded that statistically significant 
differences may not be apparent because of this problem. 2) It is 
generally acknowledged that SDAT is a heterogeneous disease 
(20,22). The patients in the advanced stages of dementia described 
before (3) were of the same age as the patients in the beginning 
stages described here. Thus, these two groups may represent 
another illustration of the heterogeneity in age of onset and/or rate 
of progression of SDAT that may be reflected by the erythrocyte 
aging process. 3) More likely, a general disturbance of the cellular 
aging system in AD/SDAT underlies neuronal degeneration and 
cell death and may affect neuronal and erythrocyte aging equally. 
The constant renewal of the erythrocyte population could prevent 
detection of such a disturbance until at an advanced stage, i.e., 
after a long period of disease progress. 4) An advanced stage of 
dementia might run parallel with a deficiency in the maintenance 
of general, organismal homeostasis. A small disturbance of the 
already increased rate of erythrocyte aging in the elderly (15) 
might very well result in changes in erythrocyte homeostasis, and, 
thus, in the values of the erythi'ocyte aging-related parameters.
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